Concentric Capital Strategies LP Takes $12.52 Million Position in Maximus, Inc. $MMS

Concentric Capital Strategies LP acquired a new stake in shares of Maximus, Inc. (NYSE:MMS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 145,014 shares of the health services provider’s stock, valued at approximately $12,518,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Dimensional Fund Advisors LP boosted its stake in shares of Maximus by 5.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,965,916 shares of the health services provider’s stock valued at $169,700,000 after purchasing an additional 96,343 shares during the period. Geode Capital Management LLC boosted its stake in shares of Maximus by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider’s stock valued at $127,952,000 after purchasing an additional 5,130 shares during the period. Boston Partners boosted its stake in shares of Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock valued at $88,236,000 after purchasing an additional 308,892 shares during the period. Norges Bank purchased a new stake in shares of Maximus during the fourth quarter valued at approximately $60,393,000. Finally, UBS Group AG boosted its stake in shares of Maximus by 76.8% during the fourth quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock valued at $52,686,000 after purchasing an additional 265,095 shares during the period. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Price Performance

MMS opened at $59.52 on Thursday. The stock has a fifty day simple moving average of $63.33 and a two-hundred day simple moving average of $75.32. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The company has a market cap of $3.13 billion, a price-to-earnings ratio of 8.91 and a beta of 0.58. Maximus, Inc. has a 12-month low of $56.92 and a 12-month high of $100.00.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Research analysts predict that Maximus, Inc. will post 8.43 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a $0.33 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. Maximus’s dividend payout ratio is 19.76%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on MMS shares. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Finally, Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, Maximus currently has an average rating of “Hold”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.